Software Healthcare Sector

Palisade Bio

Market Cap: US$3.3m

A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.

60 Degrees Pharmaceuticals

Market Cap: US$3.3m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

InMed Pharmaceuticals

Market Cap: US$3.3m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

NovaBay Pharmaceuticals

Market Cap: US$3.3m

Does not have significant operations.

AquaBounty Technologies

Market Cap: US$3.3m

Operates as a land-based aquaculture company in the United States.

RedHill Biopharma

Market Cap: US$3.2m

A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.

iCoreConnect

Market Cap: US$3.2m

A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.

CannaPharmaRX

Market Cap: US$3.2m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.

Galmed Pharmaceuticals

Market Cap: US$3.2m

A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.

NLS Pharmaceutics

Market Cap: US$3.2m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.

Artelo Biosciences

Market Cap: US$3.1m

A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.

CTT Pharmaceutical Holdings

Market Cap: US$3.1m

Engages in the development of oral drug delivery systems for pain management and treatment.

Ethema Health

Market Cap: US$3.1m

Operates behavioral healthcare space specifically in the treatment of substance use disorders.

Uscom

Market Cap: AU$4.8m

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe.

Actavia Life Sciences

Market Cap: US$3.1m

A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.

Silo Pharma

Market Cap: US$3.1m

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.

ASEP Medical Holdings

Market Cap: CA$4.2m

Focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.

Synaptogenix

Market Cap: US$3.1m

Operates as a biopharmaceutical company.

Kineta

Market Cap: US$3.1m

A clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States.

Ensysce Biosciences

Market Cap: US$3.0m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Oxford Cannabinoid Technologies Holdings

Market Cap: US$3.0m

A pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines.

Global Health

Market Cap: AU$4.7m

Provides digital health solutions for the healthcare industry in Australia.

Enveric Biosciences

Market Cap: US$3.0m

A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.

QHSLab

Market Cap: US$3.0m

A medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics.

Protagenic Therapeutics

Market Cap: US$2.9m

A biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

iSpecimen

Market Cap: US$2.8m

Operates marketplace that provides biospecimens to life science researchers worldwide.

BioTech Medics

Market Cap: US$2.8m

Operates as a medical-based holding company.

Premier Health of America

Market Cap: CA$3.9m

Engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada.

CERo Therapeutics Holdings

Market Cap: US$2.8m

An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.

9 Meters Biopharma

Market Cap: US$2.8m

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.

Bod Science

Market Cap: AU$4.3m

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.

Qualigen Therapeutics

Market Cap: US$2.8m

A clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States.

ValiRx

Market Cap: UK£2.1m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Conduit Pharmaceuticals

Market Cap: US$2.8m

A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.

Rize Oncology

Market Cap: CA$3.8m

Engages in the development of oncology therapeutics.

IQ-AI

Market Cap: UK£2.0m

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States.